Mutations in the gene encoding the human Bl T3 receptor (hTRB1) have been associated with generalized resistance to thyroid hormone (GRTH). We measured the Tg-binding affinity and transcriptional regulatory capacity of the mutant hTRB1 from four unrelated kindreds with GRTH. These mutations are contained in different functional regions of the ligand-binding domain. The T3 affinity of the mutant receptors correlated well with the degree of impairment of their frans-activating function in a transient cotransfection system in HeLa cells; two mutant receptors with undetectable ligand affinity showed no transcriptional activity, whereas the two other mutants characterized by a 2-and B-fold reduction in TS affinity required 5-and 15-fold higher T3 concentrations for half-maximal activity in the cotransfection assay, respectively. All of the mutant hTRBls were able to inhibit the function of transfected nor0s8Ess09/92/0248-0258$03.00/0 Mdeculer Endocrindogy CcpyrQht 01992
by The Endocrine Society mal hTRB1 and endogenous retinoic acid receptor in activating a palindromic positive T3 response element (TRE). In the partially functional mutants this dominant negative effect could be completely reversed by increased T3 concentrations. The dominant negative potency did not depend on the type of TRE used; mutant hTR@ls were able to inhibit normal receptor function to the same degree on a dimer-permissive palindromic TRE as on a nondimer-permissive inverted repeat of two identical halfsites separated by five spacer bases. However, the dominant negative potency was dependent on the absolute amount of receptor expression vector transfected. The expression of normal and mutant hTRB1 was assessed by immunocytochemistry. The hTRB1 protein levels in HeLa cells paralleled the amount of transfected expression vector. Moreover, all the mutant receptors were properly expressed in the nuclei of the transfected cells.
These data suggest that different mutations in the ligand-binding domain of the human hTRfl1 result in 248 
INTRODUCTION
Generalized resistance to thyroid hormone (GRTH) is an inherited disease in man characterized by the resistance of peripheral and pituitary tissues to the action of thyroid hormone (1). The disease is manifested biochemically by an inappropriately normal or elevated serum TSH level in the presence of a 2-to 4-fold elevation in the free thyroid hormone concentrations and, clinically, by evidence of decreased thyroid hormone action in peripheral tissues as well as by associated conditions such as attention deficit-hyperactivity disorder (2-4). The severity and organ distribution of resistance, however, varies considerably among unrelated kindreds. Genetic analysis of resistant kindreds has clearly linked this syndrome to the human P-T3 receptor (hTR@) gene, one of two loci encoding known thyroid hormone receptors (5). Each of these two genes, hTRa and hTRj3, produces mRNAs which can be alternatively spliced to yield the ~yl, (~2, and 81 and p2 proteins, respectively (see Ref. 6 for review). The Cal , j31, and p2 subtypes encode functional TJ receptors, which are expressed in a tissue-specific manner, whereas the (~2 protein can act as a hormone-independent inhibitor of thyroid hormone action (7-11). Mutations in portions of the hTR/? gene common to the 81 and ,82 isoforms of the receptor have been identified in a number of patients with GRTH.
Multiple mutations which alter a single amino acid in the ligand-binding domain of this receptor have been found in unrelated kindreds in which GRTH is inherited in an autosomal dominant manner (3, 4, 12, 13) . In one such kindred, designated S, a single patient homozygous for the hTR@l mutation and with severe resistance to thyroid hormone has been identified (13). In contrast, in a family with an autosomal recessive pattern of inheritance of GRTH, affected members are characterized by homozygosity for a major deletion of unknown extent of the hTR@ locus and the absence of functional P-T3 receptors but a milder degree of resistance (14). Obligate heterozygotes in this kindred have not been shown to have any clinical or biochemical abnormalities of thyroid hormone action. These data suggest that the phenotype of GRTH in heterozygous members of kindreds with autosomal dominant inheritance is not due to the lack of one functional allele for the hTRP1 but rather a manifestation of a dominant negative interference of normal receptor function by the mutant hTR@l .
The functional properties of mutant T3 receptors may be assessed in vitro by measuring the TB-binding affinity, DNA-binding affinity, and transcriptional capacity. The ligand-binding affinity has been reported to be reduced or absent for the mutant pl T3 receptors from kindreds S, A, and Mf with different mutations in the ligand-binding domain. The binding to TB response elements (TREs) was normal or increased for these receptors (13, 15, 16) . One mutant hTRP1 from kindred Mf with a point mutation in codon 340 changing a glycine to an arginine has been studied in a transient cotransfection system. It was found to lack significant ligand binding as well as transcriptional activity and to inhibit normal receptor function in a dominant negative fashion (16) . As yet there have been no data published comparing the T,-binding affinity, transcriptional capacity, and dominant negative potency of different mutant 81 T3 receptors on normal hTRP1 and retinoic acid receptor (RAR) function. Thus, the hypothesis that the marked variation in the degree and organ distribution of the resistance to thyroid hormone among different kindreds may be due to the distinct functional properties of each mutant TB receptor has not been previously addressed. Furthermore, the implications of such functional variations for the mechanism of the dominant negative effect have not been assessed.
In the present study we describe a comparison of the functional properties of the mutant pl T3 receptors from four different kindreds with GRTH. The kindreds DC, S, ED, and PV, which have been reported elsewhere (12, 13, 17) , have been chosen to represent different mutational types as well as locations within the ligandbinding domain of the hTRP gene. Two of these mutant receptors had decreased, but still detectable, T,-binding affinity; in these mutants high concentrations of T3 could normalize the transcriptional activity and the dominant negative potency. Combined with immunocytochemistry studies of transfected cells, these data allow inferences on the putative mechanism of the dominant negative action of mutant hTRB1.
RESULTS
The location and nature of the mutations in the hTR@l gene of the four kindreds studied are summarized in Table 1 . The mutations of kindreds S and DC are located within the first heptad repeat of a proposed leucine-zipper structure of the ligand-binding domain (18, 19) . The kindred ED mutation is located within the (19) . The frame-shift mutation in kindred PV alters the amino acid structure of a possible carboxy-terminal a-helical interaction subdomain (21, 22) .
The T,-binding affinities of the in vitro translated normal and mutant pl TI receptors are given in Table  2 . These data demonstrate that the deletional (kindred S) and insertional (kindred PV) mutations drastically reduce the Tg affinity, while a single base pair change three codons distal (kindred DC) to the former mutation affects T,-binding only moderately. The absence of detectable ligand binding of the receptor of kindred PV was also confirmed using hTR/Il protein expressed in Escherichia cob.
To assess the transcriptional capacity of the receptors, we transiently transfected HeLa cells with a pSV2 expression vector containing the mutant hTRP1 cDNA and a reporter plasmid with a palindromic TRE (pTREIR-MTV-CAT). Cells transfected with the wild type expression vector (pSV2-H-cerbA/3) showed half-maximal chloramphenicol-acetyl-transferase (CAT) expression at 10 nM TB. In accordance with the in vitro binding studies, transfection of either the kindred PV or S expression plasmid (pSVBPV and pSVBS, respectively) did not result in an increase in T,-dependent transcription at 1000 nM TB. However, the receptor containing the kindred DC mutation (pSV2-DC vector) could be fully activated at 100 nM TB with half-maximal activity at 50 nM TB; this agrees well with the e-fold reduction in T3 affinity as measured in vitro. Similarly the activity of the kindred ED receptor (pSVBED vector), which had a 5-fold reduced ligand affinity, could be completely normalized with half-maximal activity at 150 nM T3 (Fig.1) .
Using the same cotransfection system, we addressed the question whether the mutant receptors show any dominant negative potency and whether it is dependent on the T3 concentration. For these experiments it was essential to ensure that the reporter plasmid was present in limiting amounts relative to the amount of mutant and normal pl T3 receptors transfected. This was verified by demonstrating that increasing the quantity of pSVP-H-cerbA~ above 125 rig/l O-cm plate did not significantly elevate the absolute CAT response if 5 rg pTREIR-MTV-CAT/l O-cm plate was cotransfected. Transfection of various molar ratios of pSVBH-cerbA@ and pSVBS demonstrated a dominant negative inhibition of normal receptor function by the mutant T3 receptor ( Fig. 2) . Similar results were obtained when only 10 nM T3 were applied (data not shown).
The pl TB receptors from families DC and ED were partially functional, and a high molar excess was necessary to inhibit significantly the function of normal receptor. If the experiments were performed in the presence of 10 nM TJ the receptors from kindreds DC and ED acted by a dominant negative mechanism. By increasing the TB concentration to 100 and 1000 nM, respectively, the dominant negative potency of the DC and ED receptors could be completely reversed (Figs. 3 and 4) .
In order to exclude the possibility that the expression of the transfected pSVBH-cerbAp plasmid (0.25 pg/ plate) was impaired by the cotransfection of an up to 32-fold (8 pg/plate) excess of the expression vector for mutantreceptors, immunocytochemistry studies were performed. When HeLa cells were transfected with increasing quantities of pSVBH-cerbAB (0.25-8 pg/ plate), the levels of nuclear hTRB1 protein as detected by a monoclonal antibody directed against the A/B domain increased in parallel (Fig. 51, Table 3 ). In addition, all the four mutant receptors are expressed and properly imported into the nucleus of transfected HeLa cells (Fig. 511) . However, the expression of the receptor from kindred S was lower as compared to the other receptors.
The dominant negative effects of mutant receptors may be the result of the sequestration of accessory factors necessary for full activity of the normal receptor into inactive complexes with the mutant receptors. Consistent with this notion, the transfection of decreasing amounts of total receptor expression vector while maintaining a constant ratio of pSVP-S to pSVBH-cerbAP, resulted in a progressive reduction in the dominant negative effect of the mutant receptor (Fig. 2) . This effect occurred despite the addition of parental pSV2 vector to keep the promoter concentrations constant at all cDNA levels, indicating that the dominant negative effects are not merely the result of promoter competition for transcription factors. Alternatively, the formation of dimers between normal and mutant receptors has been proposed to mediate the dominant negative mechanism (18). In order to assess the importance of dimerization in causing the dominant negative effect observed in our transfection system, the pSVBH-cerbA@ and pSVBS expression vectors were cotransfected in a ratio of 1:4 and 1 :16 in conjunction with the pTRE,,+,-MTV-CAT reporter. In this construct, the TRE consisted of an inverted repeat of the consensus half-sites separated by 5 bases which has been shown not to support cooperative binding of receptor monomers to adjacent half-sites (23). As depicted on Fig. 6 this nondimerpermissive TRE did not eliminate the dominant negative action of the mutant receptor. Similar results were obtained with the receptor from kindred PV (data not shown). Under the conditions used in this study, the IR+5 was as strong a TRE as the unspaced IR. This finding is of interest, since it has been shown that a similar inverted repeat with a three-base pair insertion does not function as a TRE in CV-1 cells (24).
It has been shown previously that the function of RAR can be inhibited by the presence of unliganded hTR@l (25, 26) . In Fig. 7 we have compared the repressor activity of transfected normal and mutant hTR@l on the endogenous RAR in HeLa cells. It is apparent that in the presence of 500 nM retinoic acid (RA) the repressor activity of the various mutant receptors on the pTREIR-MTV-CAT reporter does not differ from that of the normal hTRB1. The results were unchanged when 0.25 rg/plate of a pRSV-hRARa expression vector was cotransfected in order to eliminate the possibility that the production of endogenous RAR was reduced by the transfection procedure. Similar results were obtained when the basal repressor activity of normal and mutant hTRP1 was assessed at the same promoter in the absence of TB and RA (data not shown).
It has been observed that kindreds with GRTH differ in the degree and organ distribution of their resistance to thyroid hormones (2, 4, 17) . Recent data demonstrating that every kindred studied so far is characterized by a distinct mutation in the hTRP1 gene suggest that the trans-activating function of the receptor may be variably affected by the mutation (3, 4, 12, 13, 17) . This is indirectly supported by differences in the T3 affinity of various mutants (13, 15, 16) . The data presented here demonstrate a good correlation between the TB affinity and the Ta concentration required for half-maximal activity (DsO) of the receptor in a transient cotransfection system. Two mutations, the deletion of a threonine in the first heptad repeat of the dimerization subdomain (codon 332) and the insertion of 1 base pair at the carboxy-terminus (codon 443), completely abolished both T3-binding and transcriptional activity of the receptor. Two other mutations changed single base pairs in the n (codon 312) and the dimerization subdomain (codon 335) and thereby reduced the T3-binding affinity and Dso severalfold; increased concentrations of Tar however, could fully activate the transcriptional capacity of both receptors.
Furthermore, we have demonstrated that all four mutant /31 T3 receptors studied not only have reduced transcriptional activity, but are also able to inhibit the trans-activating function of the normal hTR@l . Recent data on the mutant hTRB1 function from kindred Mf suggest that the transcriptional function of the human (~1 T3 receptor is decreased to a similar degree (16). Although we have shown that such an effect may occur at equimolar ratios, usually a molar excess of the mutant receptor is required. Preliminary evidence from our mutants, however, increased TJ concentrations can completely overcome their dominant negative action. Therefore, the impairment in receptor function in an individual patient with GRTH is not only determined by the type of the mutation but also by the ambient TS concentration; depending on the compensatory capacity of the pituitary-thyroid axis, the monodeiodinase systems, and membrane transporters for T3, the nuclear T3 concentration may well vary in different organs and kindreds.
The molecular mechanisms underlying the dominant negative effect are not well understood. At least three possibilities exist:
1) The normal and mutant /31 T3 receptors may compete for binding to the TRE. This mechanism is likely to occur since the mutant receptors have a normal DNA-binding affinity and in an analogous system the oncoprotein from verbA elicits its dominant negative effect mostly by competition (27) .
2) Normal and mutant pl TJ receptors could form inactive dimers. If this were the case, one must conclude that the first heptad repeat of the putative leucinezipper subdomain, whose structure is disrupted in kindred S, is not crucial for dimerization and the dominant negative effect. However, dimerization is likely to mediate the dominant negative action of artificially created mutant T3 receptors with a deleted DNA-binding domain (18, 19) . In contrast, the naturally occurring mutations in the hTRP1 described so far lie in the ligandbinding domain and have normal DNA binding (13, 15, 16) . Under these conditions, competition for binding to the TRE is expected to occur, and dimerization will make a contribution to the dominant negative action only if the affinity of mutant for normal hTR@l or the binding of mutant/normal receptor heterodimers to DNA is altered. The latter receptor properties can be indirectly assessed by comparing the ligand-independent functions of normal and mutant hTRP1 in the absence of TJ. The similar repressor activity of the normal and mutant hTRP1 on the endogenous RAR in HeLa cells, as well as the similar repression of basal gene expression on a palindromic TRE, do not support the hypothesis of an additional change in receptor function besides the reduction in T,-binding affinity. The fact that under the conditions tested the dominant negative potency of the hTRP1 from kindreds S and PV is preserved on a 
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nondimer-permissive TRE suggests that the dominant negative action may occur without the formation of dimers between normal and mutant receptors.
3) In order to regulate transcription, T3 receptors require additional general and possibly specific factors (28-31). If these are present in the cell in limiting amounts an overexpressed nonfunctional receptor could sequester these factors. Such a mechanism has been proposed to explain the inhibitory effects of the cerbA~12 protein (11). We found the dominant negative potency of the hTR/31 from kindred S to be strongly dependent on the absolute amount of receptor cDNAs transfected. This suggests a role for limiting accessory factors in mediating the dominant negative effect. Alternatively, we cannot exclude the possibility that the formation of dimers may occur more efficiently at high receptor concentrations.
The likelihood that the observed dependence of the dominant negative potency on the absolute amount of transfected receptors represents a nonspecific squelching phenomenon at the transcriptional or translational level has been minimized by keeping the amount of transfected SV40 promoter sequence constant and by establishing a parallel increase of the amount of nuclear hTRP1 protein with increasing doses of transfected cDNA.
The inhibition of the nuclear import of the normal TS receptors is another potential site of dominant negative action. By monitoring the expression of the four individually transfected mutant hTRP1 cDNAs we were able to demonstrate their proper nuclear localization. However, the receptor from kindred S with the deletion of a single amino acid was less well expressed, raising the possibility that this mutant mRNA and/or protein may have a reduced stability. Taken together, these considerations and data suggest that the dominant negative potency of mutant hTRP1 can be explained on the basis of simple competition for DNA binding and possibly for accessory factors. In addition, these experiments and the good correlation between TB-binding affinity and transcriptional capacity implicate that a reduced ligand affinity may be the sole defect in the mutant receptors from these kindreds with GRTH. Plates with HeLa cells were transfected with 5 rg pTREIR-MTV-CAT and 4 pg of either pSV2 vector without insert, pSVBHcerbAg, pSV2-ED, pSVBS, pSVBDC, or pSVBPV. After transfection 500 nM RA was added to the medium for 24 h. The results were normalized to the CAT activity observed with transfected pSV2 vector in the presence of 500 nM RA.
It is tempting to speculate that the variability in the represent a particularly complicated situation due to the clinical manifestations of the syndrome among unrelikely presence of tissue-specific transcriptional factors. lated kindreds can be explained by the different degrees
In addition, the mutations in the hTR@ gene may have in functional impairment of the mutant pl TB receptors. different functional consequences in the context of the Using the average serum thyroid hormone levels of pituitary-specific p2 receptor (32) as compared to the each of the four kindreds as a measure of the resistance hTRP1 studied here. Finally, a compensating increase to thyroid hormone, we could not find a significant in the expression of the (~1 T3 receptor has been correlation with the transcriptional capacity of the muhypothesized, and its magnitude may represent another tant pl T3 receptors from the same families (data not source of variation among kindreds. Based on the shown). However, the serum thyroid hormone levels analysis of the clinical manifestations of seven families may reflect only the pituitary resistance, which could
with GRTH it appears that unrelated kindreds vary not Vol6 No. 2 256 only in the degree of resistance but also in the spectrum of organ-specific resistance to thyroid hormone. It is conceivable that some mutations in the hTRj3 gene alter the interaction of the receptor with tissue-specific factors. The T3 receptor function as tested in ReLa cells using an ideal palindromic TRE and a viral promoter may therefore not necessarily reflect the true transcriptional capacity in different organs in ho. In future studies it will be useful to assess the function of TB receptor mutants using various cell types and natural promoters. These findings should then be correlated with the quantitative assessment of the TB responsiveness of different target organ systems in a large number of affected members from unrelated families. The elucidation of the molecular basis of the dominant negative effect of mutant T3 receptors and the associated clinical consequences should enhance our understanding of the physiological actions and interactions of T3 receptors in humans.
by the five spacer bases ACAGT. Gel shift studies with purified receptors indicate that no formation of homo-or heterodimers occurs at this element (23).
In Vitro Translation and T,-Binding Studies
The mutant and wild type human 81 receptors were synthesized using cDNAs in pGEM3 and rabbit reticulocyte lysate as oreviouslv described for the kindred S receptor (13). Brieflv, the in v&o translation reactions were prepared with the Dupont-New England Nuclear (Wilmington, DE) reticulocyte lysate L-[35S]methionine translation kit. Mutant receptors were analyzed for the appropriate size on 10% sodium dodecyl sulfate polyacrylamide gels. The nitrocellulose filter binding assay was used and has been described in detail elsewhere (13, 36) . T3 binding affinities were computed from Scatchard plots that were generated from saturation curves using L-['*~I] T3 (SA, 2200 Ci/mmol; Dupont-New England Nuclear). Scatchard points were determined from duplicate measurements, and nonspecific binding was measured in duplicate in the presence of a 1 OOO-fold excess (0.5 PM) of unlabeled T3.
MATERIALS AND METHODS

Plarmid Construction
The wild tvpe hTRfl1 expression plasmid (pSVBH-cerbAfi) was constructed from peAO4 containing the entire coding reoion of the hTRB1 cDNA (33). The EcoRl insert was liaated in6 the Hindlll site of pSV2 after the addition of Hindlll liikers. The mutant 81 T3 receptor expression vectors were created in a two-step process. First, a pGEM vector containing the mutation was constructed either by the splicing overlap extension method or the amplification of genomic DNA. Second, the mutations were subcloned into pSV8H-cerbA& The receptor cDNA for kindred S was created as previously reported (13). Then the BstXI/Bg/ll fragment containing the mutation was sequenced and subcloned into pSVP-H-cerbAP (pSVBS).
Mutant receptor cDNAs for kindred DC and kindred ED were created from wild-type receptor cDNA in peA 101 (33) usina the solicino overlap extension method (34). The ends of the amplified segment were the 5'-oligomer with a Sty1 site f5'-TGG CGA CCA ACG CCC AAG GCA GCC ACT-3') and the 3'oligomer with a Bg/ll site (5'-TAT CAT CCG CAG'ATC TGT CAC CTT CAT-3'). Complementary oligomeric pairs containing the DC and ED mutations were used in separate polymerase chain reaction amplifications to produce Styl-Bglll fragments with the respective mutations. These fragments were restricted with Sfyl and Sg/ll and inserted into the corresponding region of peAlO1. The regions created by polymerase chain amplification were completely sequenced after subcloning into peAlO to rule out spurious mutations. The BsfXl/Bg/ll fragments from these two plasmids were then subcloned into pSV2-H-cerbA& yielding the pSVP-DC and pSVP-ED expression vectors, respectively. The construction of a pGEM42 vector containing the mutation from kindred PV was prepared by cloning exon 10 of the hTRfl after amplification by the polymerase chain reaction using genomic DNA as template and oligonucleotides with EcoRl and BamHl restriction sites (pGEM-PV). The DNA fragment from the Bglll to the Hindlll restriction site containing the mutation and polylinker region of pGEM-PV was sequenced and subcloned into pSVB H-cerbAb (pSV2-PV).
The reporter plasmid pTREIR-MTV-CAT contained a palindromic T3 response element (AGGTCA) in the Hindlll site of the mouse mammary tumor virus long terminal repeat promoter with deleted glucocorticoid-response elements (35). This promoter directed the expression of the CAT gene. The pTREIR+5-MTV-CAT consisted of the same half-sites separated The Bg/ll/Hindlll fragment of pGEM-PV was subcloned into pCJ2, a vector which expresses the hTR@l in E. co/i (37). The expression of normal and mutant receptor was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis stained with Coomassie blue. Cell lysates were incubated at 4 C overnight with ['251]T3 and various amounts of unlabeled T3 (0.5, 1, 2, 4, 6, and 100 nhf) in a buffer containing 50 mM KCI, 5 mM Tris-HCI, pH 8.0, 1 mM dithiothreitol, 0.01% Lubrol, and 10% glycerol. Protein-bound T3 was separated from free TR bv ael filtration throuah G25 Sephadex columns 138). The data* were analyzed by-the LIGAND program (39) and by Scatchard analysis.
Cell Culture and Transfection
HeLa cells were plated 24 h before transfection in Dulbecco's Modified Eagle's Medium containing 10% (vol/vol) hormonedepleted fetal bovine serum (40) penicillin (100 U/ml), streptomycin (100 pg/ml), and amphotericin B (0.25 rg/ml) in locm petri dishes at a density of 1.3 x 10' cells per dish. The medium was changed 4 h before transfection. Using the calcium-phosphate method (CellPhect kit, Pharmacia-LKB, Piscataway, NJ) the cells were transfected with the appropriate plasmids. Twenty-four hours later the plates were washed once with PBS, and fresh medium was added together with the appropriate T3 or all-frans RA concentration. After another 24 h the cells were harvested, lysed, and the CAT activity determined in the extract as described (41). CAT activity was normalized for the protein concentrations measured by the Coomassie blue method. Absolute CAT conversion rates resulting from 0.25 pg/plate pSVBH-cerbA@ in the absence or presence of 100 nM T3 were typically less than 0.5% and 1 O-20%/h.50 Pg protein, respectively. A GH expression vector (pXGH5) was cotransfected to qualitatively monitor transfection efficiency. The results remain similar after correcting the CAT activities quantitatively for GH expression. However, GH secretion by the cells proved not to be an independent internal standard, and this correction was not routinely applied to the results. Similar observations concerning the use of internal transfection standards have been previously reported by others (16, 18) . All experiments were performed in duplicate or triplicate, repeated two to four times, and the data are represented as mean + sar.4. A curve of the shape CAT = [T3] x C,,/([Ta] + Dso) was fitted to the data of the T3 dose-response experiments in order to obtain accurate estimates of the Dso values. C,, represents maximal transcriptional capacity.
